Breaking News Instant updates and real-time market news.

BCYC

Bicycle Therapeutics

$29.45 /

-0.65 (-2.16%)

08:20
08/05/21
08/05
08:20
08/05/21
08:20

Bicycle Therapeutics reports Q2 EPS (74c), consensus (71c)

Reports Q2 revenue $1.79M, consensus $2.29M. Cash expected to provide financial runway through multiple clinical milestones expected in the second half of the year and into 2024.

  • 31

    Aug

  • 01

    Sep

BCYC Bicycle Therapeutics
$29.45 /

-0.65 (-2.16%)

07/15/21 Canaccord
Bicycle Therapeutics price target raised to $40 from $36 at Canaccord
07/14/21 Benchmark
Bicycle deal 'makes little sense' for Ionis, says Benchmark
07/13/21 William Blair
Bicycle collaboration a positive for Ionis, says William Blair
07/13/21 Piper Sandler
Bicycle Therapeutics price target raised to $46 from $39 at Piper Sandler

TODAY'S FREE FLY STORIES

Hot Stocks
J&J says booster shot at two months provided 94% COVID-19 protection in U.S.  06:45
09/21/21
09/21
06:45
09/21/21
06:45
JNJ

Johnson & Johnson

$163.79 /

-1.01 (-0.61%)

 
ShowHide Related Items >><<
JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades J&J to Equal Weight amid limited mid-term newsflow
JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

General news
Oil Action: » 06:45
09/21/21
09/21
06:45
09/21/21
06:45
$ECON

Economic Data

/

+

Oil Action: The front end…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Americold Realty Trust cuts FY21 warehouse same store revenue view to (2%)-0%  06:44
09/21/21
09/21
06:44
09/21/21
06:44
COLD

Americold Realty Trust

$34.50 /

-0.155 (-0.45%)

Prior view was 0%-2%.

ShowHide Related Items >><<
COLD Americold Realty Trust
$34.50 /

-0.155 (-0.45%)

COLD Americold Realty Trust
$34.50 /

-0.155 (-0.45%)

09/01/21 Barclays
Americold Realty Trust initiated with an Underweight at Barclays
08/25/21 Baird
Americold Realty Trust price target lowered to $42 from $45 at Baird
08/20/21 Truist
Americold Realty Trust price target lowered to $42 from $44 at Truist
08/09/21 Citi
Americold Realty Trust downgraded to Neutral following earnings miss at Citi
COLD Americold Realty Trust
$34.50 /

-0.155 (-0.45%)

  • 14
    Oct
Earnings
Uber now expects Q3 adjusted EBITDA ($25M)-$25M from 'better than $100M loss' » 06:44
09/21/21
09/21
06:44
09/21/21
06:44
UBER

Uber

$39.80 /

+0.055 (+0.14%)

In a regulatory filing,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBER Uber
$39.80 /

+0.055 (+0.14%)

UBER Uber
$39.80 /

+0.055 (+0.14%)

09/16/21 Evercore ISI
Evercore 'slightly less constructive' on Uber and Lyft, but still bullish
09/13/21 Goldman Sachs
Uber initiated with a Buy at Goldman Sachs
09/09/21 JPMorgan
Netflix, Uber added as top U.S. Internet picks at JPMorgan
09/01/21 Morgan Stanley
Uber can simplify balance sheet via deal with Yandex, says Morgan Stanley
UBER Uber
$39.80 /

+0.055 (+0.14%)

  • 29
    Jul
  • 08
    Jan
UBER Uber
$39.80 /

+0.055 (+0.14%)

UBER Uber
$39.80 /

+0.055 (+0.14%)

UBER Uber
$39.80 /

+0.055 (+0.14%)

Recommendations
Verrica Pharmaceuticals price target lowered to $16 from $19 at RBC Capital » 06:43
09/21/21
09/21
06:43
09/21/21
06:43
VRCA

Verrica Pharmaceuticals

$12.01 /

-0.045 (-0.37%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

06/17/21 Needham
Verrica Pharmaceuticals's Ycanth offers superior efficacy to Novan, says Needham
06/01/21 Northland
Verrica Pharmaceuticals price target lowered to $19 from $24 at Northland
05/13/21 RBC Capital
Verrica Pharmaceuticals initiated with an Outperform at RBC Capital
03/08/21 H.C. Wainwright
Verrica Pharmaceuticals price target raised to $24 from $21 at H.C. Wainwright
VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

  • 23
    Mar
VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

VRCA Verrica Pharmaceuticals
$12.01 /

-0.045 (-0.37%)

Recommendations
HealthEquity price target lowered to $75 from $92 at Deutsche Bank » 06:43
09/21/21
09/21
06:43
09/21/21
06:43
HQY

HealthEquity

$61.85 /

-2.26 (-3.53%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HQY HealthEquity
$61.85 /

-2.26 (-3.53%)

HQY HealthEquity
$61.85 /

-2.26 (-3.53%)

09/09/21 SVB Leerink
SVB Leerink 'calling a bottom,' upgrades HealthEquity to Outperform
09/09/21 SVB Leerink
HealthEquity upgraded to Outperform from Market Perform at SVB Leerink
07/01/21 Stephens
HealthEquity initiated with an Overweight at Stephens
06/10/21 Raymond James
HealthEquity price target raised to $90 from $85 at Raymond James
HQY HealthEquity
$61.85 /

-2.26 (-3.53%)

  • 17
    Aug
  • 17
    Mar
  • 17
    Feb
HQY HealthEquity
$61.85 /

-2.26 (-3.53%)

Recommendations
Vail Resorts price target raised to $301 from $298 at Deutsche Bank » 06:42
09/21/21
09/21
06:42
09/21/21
06:42
MTN

Vail Resorts

$309.85 /

+1.35 (+0.44%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MTN Vail Resorts
$309.85 /

+1.35 (+0.44%)

MTN Vail Resorts
$309.85 /

+1.35 (+0.44%)

09/20/21 KeyBanc
Vail Resorts upgraded to Overweight from Sector Weight at KeyBanc
06/08/21 BofA
Vail Resorts price target raised to $375 from $365 at BofA
06/08/21 Deutsche Bank
Vail Resorts price target raised to $298 from $294 at Deutsche Bank
06/01/21 Deutsche Bank
Vail Resorts named 'Catalyst Call: Buy Idea' at Deutsche Bank
MTN Vail Resorts
$309.85 /

+1.35 (+0.44%)

Hot Stocks
Denbury subsidiary and Mitsubishi execute term sheet for ammonia project » 06:42
09/21/21
09/21
06:42
09/21/21
06:42
DEN

Denbury

$69.68 /

-1.93 (-2.70%)

Denbury announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DEN Denbury
$69.68 /

-1.93 (-2.70%)

DEN Denbury
$69.68 /

-1.93 (-2.70%)

09/09/21 MKM Partners
Denbury initiated with a Buy at MKM Partners
07/07/21 Roth Capital
Denbury downgraded to Neutral from Buy at Roth Capital
06/24/21
Fly Intel: Top five analyst initiations
06/24/21 Stifel
Denbury initiated with a Buy at Stifel
DEN Denbury
$69.68 /

-1.93 (-2.70%)

Hot Stocks
Quarterhill subsidiary awarded C$2.2M ITD contract » 06:42
09/21/21
09/21
06:42
09/21/21
06:42
QTRH

Quarterhill

/

+

International Road…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QTRH Quarterhill
/

+

General news
European stock markets rebounded as risk appetite stabilised. » 06:40
09/21/21
09/21
06:40
09/21/21
06:40
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Sage Therapeutics appoints Chris Benecchi as Chief Commercial Officer » 06:39
09/21/21
09/21
06:39
09/21/21
06:39
SAGE

Sage Therapeutics

$45.25 /

-1.07 (-2.31%)

Sage Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SAGE Sage Therapeutics
$45.25 /

-1.07 (-2.31%)

SAGE Sage Therapeutics
$45.25 /

-1.07 (-2.31%)

08/04/21 RBC Capital
Sage Therapeutics price target lowered to $55 from $60 at RBC Capital
08/04/21 H.C. Wainwright
Sage Therapeutics price target lowered to $80 from $86 at H.C. Wainwright
07/27/21 Canaccord
Sage Therapeutics price target lowered to $96 from $119 at Canaccord
06/24/21 Piper Sandler
Piper Sandler sees 'asymmetric' risk reward for Sage Therapeutics investors
SAGE Sage Therapeutics
$45.25 /

-1.07 (-2.31%)

SAGE Sage Therapeutics
$45.25 /

-1.07 (-2.31%)

Recommendations
Entergy price target lowered to $114 from $127 at Mizuho » 06:39
09/21/21
09/21
06:39
09/21/21
06:39
ETR

Entergy

$109.50 /

-1.54 (-1.39%)

Mizuho analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ETR Entergy
$109.50 /

-1.54 (-1.39%)

ETR Entergy
$109.50 /

-1.54 (-1.39%)

08/23/21 Mizuho
Entergy price target raised to $127 from $120 at Mizuho
08/17/21 Wells Fargo
Entergy price target raised to $125 from $120 at Wells Fargo
08/17/21 Wells Fargo
Entergy price target raised to $125 from $120 at Wells Fargo
08/05/21 Citi
Entergy price target raised to $110 from $101 at Citi
ETR Entergy
$109.50 /

-1.54 (-1.39%)

ETR Entergy
$109.50 /

-1.54 (-1.39%)

Upgrade
South State upgraded to Buy from Neutral at DA Davidson » 06:39
09/21/21
09/21
06:39
09/21/21
06:39
SSB

South State

$63.76 /

-1.01 (-1.56%)

DA Davidson analyst Kevin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSB South State
$63.76 /

-1.01 (-1.56%)

SSB South State
$63.76 /

-1.01 (-1.56%)

08/16/21
Fly Intel: Top five analyst downgrades
08/16/21 Stephens
South State downgraded to Equal Weight from Overweight at Stephens
07/27/21 Truist
South State price target lowered to $90 from $100 at Truist
07/27/21 Piper Sandler
Atlantic Capital downgraded to Neutral from Overweight at Piper Sandler
SSB South State
$63.76 /

-1.01 (-1.56%)

Recommendations
MSCI price target raised to $720 from $650 at RBC Capital » 06:38
09/21/21
09/21
06:38
09/21/21
06:38
MSCI

MSCI

$634.57 /

-7.14 (-1.11%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSCI MSCI
$634.57 /

-7.14 (-1.11%)

MSCI MSCI
$634.57 /

-7.14 (-1.11%)

08/03/21 Deutsche Bank
MSCI price target raised to $650 from $600 at Deutsche Bank
07/28/21 Oppenheimer
MSCI price target raised to $626 from $566 at Oppenheimer
07/28/21 Deutsche Bank
MSCI price target raised to $600 from $525 at Deutsche Bank
07/28/21 Barclays
MSCI price target raised to $700 from $545 at Barclays
MSCI MSCI
$634.57 /

-7.14 (-1.11%)

Hot Stocks
Johnson & Johnson announces new data on COVID-19 vaccine » 06:37
09/21/21
09/21
06:37
09/21/21
06:37
JNJ

Johnson & Johnson

$163.79 /

-1.01 (-0.61%)

Johnson & Johnson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

09/16/21 Jefferies
Genmab downgraded to Hold from Buy at Jefferies
09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades J&J to Equal Weight amid limited mid-term newsflow
JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

JNJ Johnson & Johnson
$163.79 /

-1.01 (-0.61%)

Earnings
Americold Realty Trust cuts FY21 AFFO view to 1.15-$1.20 from $1.34-$1.40 » 06:37
09/21/21
09/21
06:37
09/21/21
06:37
COLD

Americold Realty Trust

$34.50 /

-0.155 (-0.45%)

FY21 consensus $1.34.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COLD Americold Realty Trust
$34.50 /

-0.155 (-0.45%)

COLD Americold Realty Trust
$34.50 /

-0.155 (-0.45%)

09/01/21 Barclays
Americold Realty Trust initiated with an Underweight at Barclays
08/25/21 Baird
Americold Realty Trust price target lowered to $42 from $45 at Baird
08/20/21 Truist
Americold Realty Trust price target lowered to $42 from $44 at Truist
08/09/21 Citi
Americold Realty Trust downgraded to Neutral following earnings miss at Citi
COLD Americold Realty Trust
$34.50 /

-0.155 (-0.45%)

  • 14
    Oct
Hot Stocks
FDA clears Oric Pharma's IND for ORIC-533 » 06:36
09/21/21
09/21
06:36
09/21/21
06:36
ORIC

Oric Pharmaceuticals

$24.54 /

-0.67 (-2.66%)

ORIC Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy after tumor data at Citi
07/06/21 Citi
Oric Pharmaceuticals upgraded to Buy from Neutral at Citi
03/25/21 H.C. Wainwright
Oric Pharmaceuticals price target raised to $54 from $52 at H.C. Wainwright
01/25/21 Citi
Oric Pharmaceuticals downgraded to Neutral from Buy at Citi
ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

  • 13
    Nov
ORIC Oric Pharmaceuticals
$24.54 /

-0.67 (-2.66%)

Recommendations
Citi survey shows Nike 'back in favor' with Chinese consumer » 06:35
09/21/21
09/21
06:35
09/21/21
06:35
NKE

Nike

$154.23 /

-2.25 (-1.44%)

Citi analyst Paul Lejuez…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

09/20/21 Deutsche Bank
Nike price target lowered to $171 from $179 at Deutsche Bank
09/20/21 Piper Sandler
Nike supply chain disruptions creates buying opportunity, says Piper Sandler
09/13/21
Fly Intel: Top five analyst downgrades
09/13/21 BTIG
BTIG downgrades Nike on 'severe supply chain disruptions' in Vietnam
NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

NKE Nike
$154.23 /

-2.25 (-1.44%)

Recommendations
Axalta Coating price target lowered to $36 from $38 at RBC Capital » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
AXTA

Axalta Coating

$27.96 /

-0.61 (-2.14%)

RBC Capital analyst Arun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

09/15/21 BofA
Axalta Coating removed from US 1 List at BofA
09/09/21 Citi
Axalta Coating downgraded to Neutral from Buy at Citi
09/09/21 Citi
Axalta Coating downgraded to Neutral from Buy at Citi
07/28/21 Deutsche Bank
Axalta Coating price target lowered to $36 from $38 at Deutsche Bank
AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

AXTA Axalta Coating
$27.96 /

-0.61 (-2.14%)

Hot Stocks
Aerie Pharmaceuticals says Vicente Anido, PhD no longer serving as CEO » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
AERI

Aerie Pharmaceuticals

$11.59 /

-1.27 (-9.88%)

Aerie Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

11/09/20 H.C. Wainwright
Aerie Pharmaceuticals price target lowered to $29 from $31 at H.C. Wainwright
10/28/20 H.C. Wainwright
Aerie Pharmaceuticals $50M upfront should reduce overhang, says H.C. Wainwright
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
10/19/20 BofA
Aerie Pharmaceuticals downgraded to Underperform from Neutral at BofA
AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

AERI Aerie Pharmaceuticals
$11.59 /

-1.27 (-9.88%)

Initiation
Citi Trends initiated with a Buy at Benchmark » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
CTRN

Citi Trends

$70.61 /

+0.5 (+0.71%)

Benchmark analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CTRN Citi Trends
$70.61 /

+0.5 (+0.71%)

CTRN Citi Trends
$70.61 /

+0.5 (+0.71%)

08/25/21 Craig-Hallum
Citi Trends price target raised to $165 from $150 at Craig-Hallum
05/26/21 Craig-Hallum
Citi Trends price target raised to $150 from $142 at Craig-Hallum
04/15/21 Craig-Hallum
Citi Trends price target raised to $142 from $125 at Craig-Hallum
03/17/21 Craig-Hallum
Citi Trends price target raised to $125 from $93 at Craig-Hallum
CTRN Citi Trends
$70.61 /

+0.5 (+0.71%)

Earnings
Apogee Enterprises sees FY22 adjusted EPS $2.20-$2.40, consensus $2.28 » 06:34
09/21/21
09/21
06:34
09/21/21
06:34
APOG

Apogee Enterprises

$39.34 /

-1.09 (-2.70%)

The company previously…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

06/28/21 Craig-Hallum
Apogee Enterprises price target raised to $48 from $43 at Craig-Hallum
04/09/21 DA Davidson
Apogee Enterprises price target raised to $33 from $28 at DA Davidson
12/21/20 Craig-Hallum
Apogee Enterprises price target raised to $39 from $31 at Craig-Hallum
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

Hot Stocks
Activision Blizzard says working with regulators to address workplace complaints » 06:33
09/21/21
09/21
06:33
09/21/21
06:33
ATVI

Activision Blizzard

$76.20 /

-3.415 (-4.29%)

, DIS

Disney

$178.63 /

-4.865 (-2.65%)

Activision Blizzard…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

09/15/21 KeyBanc
EA's delay of Battlefield 2042 slight positive for Activision, says KeyBanc
09/15/21 Benchmark
EA shares reacting negatively to Battlefield 2042 delay rumors, says Benchmark
09/15/21 Truist
Battlefield 2042 delay would be 'modest negative' for EA, says Truist
09/13/21 JPMorgan
Activision should be bought on China regulation concerns, says JPMorgan
DIS Disney
$178.63 /

-4.865 (-2.65%)

05:19 Today Daiwa
Disney initiated with a Buy at Daiwa
09/13/21 Stephens
Recent Apple TV+ news positive for Roku, says Stephens
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
09/09/21 Arete
Disney initiated with a Buy at Arete
ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

ATVI Activision Blizzard
$76.20 /

-3.415 (-4.29%)

DIS Disney
$178.63 /

-4.865 (-2.65%)

Hot Stocks
Verso enters confidentiality agreement with Atlas Holdings » 06:32
09/21/21
09/21
06:32
09/21/21
06:32
VRS

Verso

$19.38 /

-0.13 (-0.67%)

Verso announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRS Verso
$19.38 /

-0.13 (-0.67%)

VRS Verso
$19.38 /

-0.13 (-0.67%)

08/09/21 B. Riley
Verso downgraded to Neutral on valuation at B. Riley
08/09/21 B. Riley
Verso downgraded to Neutral from Buy at B. Riley
07/13/21 BWS Financial
Atlas proposal 'materially undervalues' Verso, says BWS Financial
05/10/21 BWS Financial
Verso price target raised to $30 from $25.50 at BWS Financial
Earnings
Apogee Enterprises reports Q2 adjusted EPS 53c, consensus 55c » 06:31
09/21/21
09/21
06:31
09/21/21
06:31
APOG

Apogee Enterprises

$39.34 /

-1.09 (-2.70%)

Reports Q2 revenue $326M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

06/28/21 Craig-Hallum
Apogee Enterprises price target raised to $48 from $43 at Craig-Hallum
04/09/21 DA Davidson
Apogee Enterprises price target raised to $33 from $28 at DA Davidson
12/21/20 Craig-Hallum
Apogee Enterprises price target raised to $39 from $31 at Craig-Hallum
APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

APOG Apogee Enterprises
$39.34 /

-1.09 (-2.70%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.